HC and PHAC - #COVID19 updates - Promoting and protecting Canadians' health and safety - Français: @GouvCanSante - Notice: https://t.co/o7tmpUpODG
Sep 1, 2022 • 5 tweets • 2 min read
(1/5) Following authorization of Moderna’s bivalent #Covid19 vaccine by Health Canada for adults 18+, the National Advisory Committee on Immunization (NACI) has made recommendations on the use of this vaccine as a booster dose in Canada 👇 ow.ly/hygL50KxQhy
(2/5) Adults 18+ should be offered a bivalent vaccine. If this is not readily available, an original mRNA booster should be offered to ensure timely protection.
Sep 1, 2022 • 4 tweets • 1 min read
(1/4) Health Canada has authorized an adapted version of the Moderna Spikevax COVID-19 vaccine that targets two coronavirus strains, for adults 18 years of age and older. ow.ly/kw3B50KxV0X
(2/4) After a thorough and independent scientific review of the evidence, Health Canada has determined that the bivalent Moderna Spikevax booster is safe and effective.
Jul 14, 2022 • 5 tweets • 2 min read
(1/5) Following Health Canada approval, the National Advisory Committee on Immunization (NACI) recommends that a 2-dose primary series of the Moderna Spikevax #CovidVaccine#Under5 may be offered to children 6 months to 5 yrs. Learn more: ow.ly/Vmx150JVZVk
(2/5) NACI carefully reviewed the available evidence, and like other age groups, recommends a 2-dose primary series with an interval of 8 weeks between the 1st and 2nd dose.
May 26, 2022 • 7 tweets • 2 min read
(1/7) Today, PHAC has confirmed additional cases of #monkeypox. There are now 26 confirmed cases in Canada. The breakdown by province is: Quebec (25) and Ontario (1). ow.ly/oTHe30skE9J
(2/7) Human cases of monkeypox have been recently reported in over 20 countries worldwide. Before now, Canada has not seen person-to-person spread of monkeypox.
Jan 17, 2022 • 5 tweets • 2 min read
(1/5) Health Canada has authorized the first #Covid19 treatment in pill form that can be used at home to help prevent serious disease. ow.ly/24cN50Hw7SC
(2/5) The combination of two antiviral drugs, nirmatrelvir and ritonavir (brand name PAXLOVIDTM), is authorized to treat mild to moderate #Covid19 in adults at high risk of progressing to serious disease, including hospitalization or death.
Sep 16, 2021 • 5 tweets • 1 min read
(1/4) Health Canada has authorized brand name changes for the Pfizer-BioNTech, Moderna and AstraZeneca COVID-19 vaccines.
(2/4) The Pfizer-BioNTech vaccine will now be named Comirnaty, the Moderna vaccine will be named SpikeVax, and the AstraZeneca vaccine will be named Vaxzevria.